SFX by Ex Libris Inc.

Title:	Elucidating the risk of Parkinson's disease
Source:	Science [0036-8075] Zahn, L M yr:2017

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	"Neurodegeneration: Parkinson's propagator." Nature 478.7368 (2011): 158-158.
description	2.	Wichmann, T. "Models of Parkinson's disease revisited." Nature 557.7704 (2018): 169-170.
description	3.	Cortese, M. "Urate and the risk of Parkinson's disease in men and women." Parkinsonism & related disorders. 52: 76-82.
description	4.	De Pablo-Fernández, E. "Neuroendocrine abnormalities in Parkinson's disease." Journal of Neurology, Neurosurgery and Psychiatry 88.2 (2017): 176-185.
description	5.	Grayson, M. "Parkinson's disease." Nature 466.7310 (2010): 1-.
description	6.	Samii, A. "Parkinson's disease." The lancet 365.9459: 1783-1793.
description	7.	"Neurobiology: Protecting neurons from Parkinson's." Nature 501.7465 (2013): 9-9.
description	8.	Bolitho SJ, S M W J. "Disturbances in melatonin secretion and circadian sleep-wake regulation in Parkinson disease." Sleep medicine 15.3 (2014): 342-7.
description	9.	"Synthetic Parkinson's." Science 338.6109 (2012): 862-862.
description	10.	Katsnelson, A. "Experimental therapies for Parkinson's disease: Why fake it?" Nature 476.7359 (2011): 142-144.
description	11.	Martinez Martin, P. "Gender-related differences in the burden of non-motor symptoms in Parkinson's disease." Journal of neurology 259.8 (2012): 1639-1647.
description	12.	Samii, R. "Parkinson's disease." The lancet 363.North-American-Editi (2004): 1783-1793.
description	13.	Rocca, Walter A. "Risk factors for parkinson's disease may differ in men and women: An exploratory study." Hormones and behavior 63.2 (2012): 308-14.
description	14.	Deweerdt, S. "Parkinson's disease: 4 big questions." Nature 538.7626 (2016).
description	15.	Li, W. "Structural changes of gut microbiota in Parkinson's disease and its correlation with clinical features." Science China(Life Sciences) 60.11 (2017): 1223-1233.
description	16.	Abdelkader, Noha F. "Ursodeoxycholic Acid Ameliorates Apoptotic Cascade in the Rotenone Model of Parkinson’s Disease: Modulation of Mitochondrial Perturbations." Molecular Neurobiology 53.2 (2016): 810-817.
description	17.	Lotia, M. "New and Emerging Medical Therapies in Parkinson’s Disease." Expert opinion on pharmacotherapy 17.7 (2016): 1-15.
description	18.	Ascherio, A. "Prospective study of plasma urate and risk of Parkinson disease in men and women." Neurology 86.6 (2016): 520-6.
description	19.	Holemans, T. "A lipid switch unlocks Parkinson's disease-associated ATP13A2." Proceedings of the National Academy of Sciences of the United States of America 112.29 (2015): 9040-5.
description	20.	Lee, Joanna M. "What matters to people with Parkinson’s disease living in Australia?" Journal of clinical neuroscience 22.2 (2014): 338-341.